In this article
Coffee Consumption and Reduced Risk of Liver Cancer
A study showed that drinking more coffee can reduce the risk of developing the most common primary liver cancer. Researchers from the University of Southampton and the University of Edinburgh found that the more coffee you drink, the less likely it is to develop hepatocellular carcinoma (HCC). Drinking a cup of caffeinated coffee every day can reduce the risk of liver cancer by 20%, and drinking two cups of coffee can reduce the risk of liver cancer by 35%. If you drink as many as five cups of coffee a day, the risk of liver cancer will be halved.
For people who drink coffee for a long time and those who do not drink coffee often, this protective effect of coffee is the same. The more coffee you drink, the greater the effect of preventing liver cancer-although more than five cups of coffee a day There is very little data. Caffeine-free coffee is also beneficial for preventing liver cancer, although the effect is not so obvious.
Scientific Evidence and Health Implications of Coffee Intake
The data of 26 observational studies were carefully analyzed and included more than 2.25 million participants. This latest study calculated the relative risk of hepatocellular carcinoma (HCC) among people who drink one to five cups of caffeinated coffee every day. It is generally believed that coffee has many health benefits, and these latest research results show that coffee has a significant impact on liver cancer risk.
We do not recommend that everyone drink five cups of coffee every day. It is necessary to discuss more about the potential hazards of ingesting caffeinated coffee in large quantities. There is already evidence that in certain groups (such as pregnant women) should avoid drinking too much coffee. Compound molecules found in coffee have beneficial properties such as anti-oxidation, anti-inflammatory, and anti-cancer. Scientists believe that this can be used to explain that people who drink coffee are less likely to suffer from chronic liver disease and liver cancer. Studies have shown that the effect of coffee on reducing liver cirrhosis and liver cancer is dose-dependent. There have also been reports that coffee can reduce the risk of death from many other causes. As long as coffee is not excessive, it is an excellent natural medicine. Dr. Kennedy said the next step is to investigate whether increasing coffee intake is effective for people at high risk of liver cancer through randomized trials.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
About Susan Hau
Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy. Hau's expertise lies in cancer cell biolo…
✓ Reviewed for medical accuracy by the CancerFax review panel.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.